Podcast

Twenty-five antiretroviral agents have been marketed in the United States for the treatment of human immunodeficiency virus (HIV) infection/AIDS. The classification of these agents is reviewed and the properties of the five newest antiretroviral agents are discussed in detail. The specific indications for which the use of the new agents is recommended are identified, as are the risks and limitations of their use. The advantages and disadvantages of the new agents are considered in the context of comparisons with previously marketed antiretroviral agents. A rating (on a scale of 1 to 5) for each of the new drugs is provided based on an evaluation of their advantages and disadvantages

This presentation will cover major threats to global health, including current and emerging infectious diseases.

Many people involved in health outreach in developing nations realize that sustainable improvement requires that the local community be empowered rather than be seen as passive recipients of aid. But there is no clear and commonly held definition of empowerment. What does it mean? How, if at all, can it be measured? What does it take to create empowerment? MAP International and the Rollins School of Public Health at Emory University are engaged in research on that topic. In addition to a thorough literature review, they have surveyed 49 global NGOs (non-governmental organizations) and faith-based organizations to learn from their thinking and experience.

One fifth of the world have no access to health care. Community based models hold keys to success. Primary Health Care is a WHO priority. Faith Based Organisations are invited to participate. By working together and demonstrating excellence we can bring change, health and hope in the name of Christ.